19 results
·
23ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
PICC Tip Positioning Aid
FDA 510(k)
FDA Class 2
·General Hospital
Acetabular Reamers
FDA UDI
SIGNATURE ORTHOPAEDICS PTY LTD·09348215039158·
OrthoMedFlex
FDA UDI
ORTHOMEDFLEX LLC·M7161121522610·Bridgeback Acetabular Reamer, Size 61mm
MODIFICATION TO: VERTE-STACK SPINAL SYSTEM
FDA 510(k)
FDA Class 2
·Orthopedic
DISCOVERY XR656 WITH VOLUMERAD (DIGITAL TOMOSYNTHESIS)
FDA 510(k)
FDA Class 2
·Radiology
MANUAL ORTHOPEDIC SURGICAL INSTRUMENT
FDA Adverse Event
Injury
·MEDTRONIC SOFAMOR DANEK USA, INC.·Product code LXH·March 31, 2010
SPINAL VERTEBRAL BODY REPLACEMENT DEVICE
FDA Adverse Event
Injury
·MEDTRONIC SOFAMOR DANEK·Product code MQP·July 3, 2018
CAPSUREFIX NOVUS
FDA Adverse Event
Malfunction
·MPRI·Product code DTB·June 7, 2013
KINETRA
FDA Adverse Event
Malfunction
·MEDTRONIC NEUROMODULATION·Product code MHY·June 23, 2011
VERSACARE
FDA Adverse Event
Malfunction
·HILL-ROM RITTER·Product code FNL·September 10, 2008
ALINITY I SYPHILIS TP REAGENT KIT
FDA Adverse Event
Malfunction
·ABBOTT GMBH·Product code LIP·October 16, 2025
ALINITY I ANTI-HCV REAGENT KIT
FDA Adverse Event
Malfunction
·ABBOTT GMBH·Product code MZO·October 16, 2025
ARCHITECT ANTI-HBC II
FDA Adverse Event
Malfunction
·ABBOTT GMBH·Product code LOM·October 16, 2025
ARCHITECT HBSAG QUALITATIVE II
FDA Adverse Event
Malfunction
·ABBOTT IRELAND DIAGNOSTICS DIVISION·Product code LOM·October 16, 2025
ARCHITECT SYPHILIS TP
FDA Adverse Event
Malfunction
·ABBOTT GMBH·Product code LIP·October 16, 2025
ALINITY I ANTI-HBC II REAGENT KIT
FDA Adverse Event
Malfunction
·ABBOTT GMBH·Product code LOM·October 16, 2025
ARCHITECT ANTI-HCV
FDA Adverse Event
Malfunction
·ABBOTT GMBH·Product code MZO·October 16, 2025
ALINITY I HBSAG QUALITATIVE II REAGENT KIT
FDA Adverse Event
Malfunction
·ABBOTT IRELAND DIAGNOSTICS DIVISION·Product code LOM·October 16, 2025
SL & SLi Series (Mod 15/18/20/25) Linear Accelerator Used for radiation therapy treatments of malignant neoplastics diseases.
FDA Enforcement
Class II
·Terminated·Elekta, Inc.·March 26, 2014